Mirodenafil dihydrochloride clinical trials
Also written SK3530.
A product of Mirodenafil; its studies count on that page too.
How each study uses mirodenafil dihydrochloride is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
Studies by the year they started
6 studies that test it; most in 2007 (4)
| Year | Studies |
|---|---|
| 2004 | 1 |
| 2006 | 1 |
| 2007 | 4 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 6 · Other 0
Related medicines
As reviewed, each with the page that says it.
- A salt or form of Mirodenafil
- One of PDE5 inhibitors source
Studies
Open first, then newest update. How each study uses mirodenafil dihydrochloride is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 6
- Phase 1 Study of SK3530 to Investigate of the Effect of FoodCompletedPhase 1SK Chemicals Co., Ltd.NCT00443625Written as SK3530How we know
- Phase III Study to Assess the Efficacy and Safety of SK3530 in Patients With Erectile Dysfunction and HypertensionCompletedPhase 3SK Chemicals Co., Ltd.NCT00644007Written as SK3530How we know
- Study to Assess the Efficacy and Safety of SK3530 on Erectile Dysfunction in Patients With Diabetes MellitusCompletedPhase 3SK Chemicals Co., Ltd.NCT00705861Written as SK3530How we know
- Phase I Study to Investigate the Alcohol Interaction of SK3530CompletedPhase 1SK Chemicals Co., Ltd.NCT00489450Written as SK3530How we know
- Phase I Study to Investigate the Drug Interaction After Oral Administration of Tamsulosin and SK3530CompletedPhase 1SK Chemicals Co., Ltd.NCT00489606Written as SK3530How we know
- Phase II Trial of SK3530 in Erectile DysfunctionTerminatedPhase 2SK Chemicals Co., Ltd.NCT00351065Written as SK3530How we know
Codes
What other systems call mirodenafil dihydrochloride · ClinicalTrials.gg INT005066
- UNII (FDA) NL7L8TWT8YMIRODENAFIL DIHYDROCHLORIDEOne source FDA
- NCI Thesaurus C218077Mirodenafil DihydrochlorideOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | NL7L8TWT8Y | MIRODENAFIL DIHYDROCHLORIDE | One source FDA |
| NCI Thesaurus | C218077 | Mirodenafil Dihydrochloride | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.